Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial. (Q42616224)

From Wikidata
Jump to navigation Jump to search
scientific article published on 9 March 2009
edit
Language Label Description Also known as
English
Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial.
scientific article published on 9 March 2009

    Statements

    Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit